Previous Page  22 / 35 Next Page
Information
Show Menu
Previous Page 22 / 35 Next Page
Page Background

Routine molecular profiling is the only way to

identify all potential patients candidates to receive

targeted treatment

Large-scale molecular testing challenges

Quality

Reproducibility

Unrestricted access

Adequate turn-around time

Routine molecular profiling in France

(Barlessi F. et al, Lancet 2016)

Feasibility of the implementation of large-scale nationwide

decentralized testing,

Tests free of charge for patients and institutions.

Improvement in the survival of about 50% of patients

1